Advanced
  Home Compare Reports

Comparison with Similar Reports

Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, H...

Publisher:        MarketsandMarkets

# of Pages:        220

Rating: 

1 User License $4,950

Publication Date:  March, 2021

Price:       $4,950 / User License




TABLE OF CONTENTS

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED FOR THE STUDY 31
1.3.3 CURRENCY 32
1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 32
1.4 STAKEHOLDERS 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIOMÉRIEUX 39
FIGURE 6 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020) 40
FIGURE 7 DEMAND-SIDE ANALYSIS 41
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2021–2026) 42
FIGURE 10 TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ANALYSIS 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 LIMITATIONS/RISK ASSESSMENT 45
2.7 COVID-19 HEALTH ASSESSMENT 46
2.8 COVID-19 ECONOMIC ASSESSMENT 46
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 46
FIGURE 12 CRITERIA IMPACTING THE GLOBAL ECONOMY 47
FIGURE 13 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 48
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 14 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2021 VS. 2026 50
FIGURE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2021 VS. 2026 51
FIGURE 16 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2021 VS. 2026 51
FIGURE 17 GEOGRAPHIC SNAPSHOT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 52
4 PREMIUM INSIGHTS 54
4.1 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET OVERVIEW 54
FIGURE 18 GROWING ANIMAL POPULATION AND INCREASING ANIMAL HEALTHCARE EXPENDITURE ARE KEY FACTORS DRIVING MARKET GROWTH 54
4.2 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT 55
FIGURE 19 DISKS & PLATES COMMANDED THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2020 55
4.3 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC MIX 56
FIGURE 20 CHINA TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DURING THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 MARKET DRIVERS 58
5.2.1.1 Growing threat of antimicrobial resistance due to overuse of antibiotics 58
FIGURE 22 SALES AND DISTRIBUTION OF ANTIMICROBIAL DRUGS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS IN THE US (2010–2019) 58
5.2.1.2 Rising demand for animal-derived food products 59
TABLE 1 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS 59
TABLE 2 SIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 60
TABLE 3 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 60
FIGURE 23 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD
IN 2018 61
5.2.1.3 Growing prevalence of zoonotic diseases 61
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 62
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure 62
FIGURE 24 US: PET INDUSTRY EXPENDITURE, 2010–2019 63
5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies 64
TABLE 5 NUMBER OF VETERINARIANS AND PARA-VETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 64
TABLE 6 MARKET DRIVERS: IMPACT ANALYSIS 65
5.2.2 MARKET RESTRAINTS 65
5.2.2.1 High cost of automated veterinary antimicrobial susceptibility testing systems 65
5.2.2.2 Rising pet care costs 65
TABLE 7 MARKET RESTRAINTS: IMPACT ANALYSIS 66
5.2.3 MARKET OPPORTUNITIES 66
5.2.3.1 Rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives 66
5.2.3.2 Growth in the companion animal population 67
TABLE 8 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION) 68
TABLE 9 MARKET OPPORTUNITY: IMPACT ANALYSIS 68
5.2.4 MARKET CHALLENGES 69
5.2.4.1 Low awareness about antimicrobial resistance in veterinarians and livestock farmers 69
5.2.4.2 Limited guidelines for interpretation of veterinary antimicrobial susceptibility test results 69
5.2.4.3 Shortage of veterinary practitioners and skilled veterinary pathologists in developing markets 70
TABLE 10 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY,
2005 VS. 2014 VS. 2018 70
TABLE 11 MARKET CHALLENGES: IMPACT ANALYSIS 71
5.3 TECHNOLOGICAL ANALYSIS 71
FIGURE 25 TECHNOLOGICAL ADVANCEMENTS ARE A MAJOR TREND IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 71
5.4 PRICING ANALYSIS 71
TABLE 12 REGIONAL PRICING ANALYSIS OF AUTOMATED AST INSTRUMENTS,
2019 (USD) 72
5.5 VALUE CHAIN ANALYSIS 72
FIGURE 26 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VALUE CHAIN ANALYSIS 73
5.6 ECOSYSTEM MARKET MAP 73
FIGURE 27 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP 74
FIGURE 28 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP 74
5.7 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 13 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.7.1 THREAT FROM NEW ENTRANTS 75
5.7.2 INTENSITY OF COMPETITIVE RIVALRY 75
5.7.3 BARGAINING POWER OF BUYERS 76
5.7.4 BARGAINING POWER OF SUPPLIERS 76
5.7.5 THREAT FROM SUBSTITUTES 76
5.8 SUPPLY CHAIN ANALYSIS 76
FIGURE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS 78
5.9 IMPACT OF COVID-19 ON THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 78
5.10 REGULATORY ANALYSIS 79
5.11 PATENT ANALYSIS 79
5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS 79
FIGURE 30 PATENT PUBLICATION TRENDS (2015–2020) 80
5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS 80
FIGURE 31 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS (2015–2021) 80
5.12 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES 81
TABLE 14 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES 81
5.13 CUSTOMIZED VS. PORTFOLIO PRODUCTS 82
6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT 83
6.1 INTRODUCTION 84
TABLE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 84
6.2 DISKS & PLATES 84
6.2.1 DISKS & PLATES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET IN 2020 84
TABLE 16 LEADING DISKS & PLATES AVAILABLE IN THE MARKET FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING (2020) 85
TABLE 17 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DISKS & PLATES, BY COUNTRY, 2019–2026 (USD MILLION) 86
6.3 CULTURE MEDIA 86
6.3.1 CONSTANT REQUIREMENT AND REPETITIVE PURCHASE OF CULTURE MEDIA TO DRIVE MARKET GROWTH 86
TABLE 18 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION) 87
6.4 ACCESSORIES & CONSUMABLES 88
6.4.1 WIDE USE OF MANUAL METHODS LIKE DISK DIFFUSION WILL DRIVE THE GROWTH OF THIS SEGMENT 88
TABLE 19 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ACCESSORIES & CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION) 88
6.5 AUTOMATED AST INSTRUMENTS 89
6.5.1 ONGOING TREND OF LABORATORY AUTOMATION TO DRIVE GROWTH IN THIS MARKET SEGMENT 89
TABLE 20 ADVANTAGES OF AUTOMATED AST OVER DISKS & PLATES 89
TABLE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AUTOMATED AST INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 90
7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE 91
7.1 INTRODUCTION 92
TABLE 22 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 92
7.2 FOOD-PRODUCING ANIMALS 92
FIGURE 32 MARKET FOR CATTLE TO DOMINATE THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS DURING THE FORECAST PERIOD 93
TABLE 23 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 24 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 94
7.2.1 CATTLE 94
7.2.1.1 Increasing cattle population and growing consumption of meat to drive growth in the veterinary AST market 94
TABLE 25 EXAMPLES OF CATTLE-RELATED AMR HUMAN HEALTH THREATS 95
TABLE 26 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 96
TABLE 27 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION) 97
7.2.2 PIGS 97
7.2.2.1 Growing incidence of infectious diseases will support market growth 97
TABLE 28 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 98
FIGURE 33 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS) 98
TABLE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION) 99
7.2.3 POULTRY 99
7.2.3.1 Growing infectious disease prevalence in poultry will support the growth of the veterinary antimicrobial susceptibility testing market 99
FIGURE 34 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS) 100
TABLE 30 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION) 100
TABLE 31 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION) 101
7.2.4 OTHER FOOD-PRODUCING ANIMALS 101
TABLE 32 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 102
7.3 COMPANION ANIMALS 102
TABLE 33 POPULATION OF DOGS AND CATS, BY COUNTRY, 2012–2019 (MILLION) 103
FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS DURING THE FORECAST PERIOD 103
TABLE 34 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 35 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 104
7.3.1 DOGS 105
7.3.1.1 Dogs dominate the veterinary antimicrobial susceptibility testing market for companion animals 105
TABLE 36 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION) 105
TABLE 37 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION) 106
7.3.2 CATS 106
7.3.2.1 Increasing pet cat population to drive market growth 106
TABLE 38 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION) 107
TABLE 39 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.3.3 HORSES 108
7.3.3.1 Growing equine health awareness will drive the market growth 108
TABLE 40 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND) 108
TABLE 41 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION) 109
7.3.4 OTHER COMPANION ANIMALS 109
TABLE 42 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 110
8 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER 111
8.1 INTRODUCTION 112
TABLE 43 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 112
8.2 VETERINARY REFERENCE LABORATORIES 112
8.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTS 112
TABLE 44 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 113
8.3 VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES 113
8.3.1 INCREASING FUNDING FOR RESEARCH ON ANTIMICROBIAL RESISTANCE AND AST IN UNIVERSITIES TO BOOST MARKET GROWTH 113
TABLE 45 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION) 114
8.4 OTHER END USERS 115
TABLE 46 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 115
9 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION 116
9.1 INTRODUCTION 117
FIGURE 36 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 117
TABLE 47 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION) 118
9.2 NORTH AMERICA 118
FIGURE 37 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 119
FIGURE 38 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 120
TABLE 48 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 120
TABLE 49 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 121
TABLE 50 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 121
TABLE 51 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 52 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 53 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 122
9.2.1 US 122
9.2.1.1 The US dominated the North American veterinary antimicrobial susceptibility testing market in 2020 122
FIGURE 39 US: EXPENDITURE ON VET VISITS 123
FIGURE 40 US: NUMBER OF VETERINARIANS, 2014–2019 124
TABLE 54 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 124
FIGURE 41 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG) 125
TABLE 55 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014 VS. 2019 125
TABLE 56 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 126
TABLE 57 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 126
TABLE 58 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 59 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 60 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 127
9.2.2 CANADA 127
9.2.2.1 Slow economic growth in Canada severely affects its share in the North American Market 127
TABLE 61 CANADA: LARGE ANIMAL POPULATION, 2001–2014 (MILLION) 128
TABLE 62 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 128
TABLE 63 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 129
TABLE 64 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 65 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 66 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 130
9.3 EUROPE 130
TABLE 67 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 68 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 131
TABLE 69 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 132
TABLE 70 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 71 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 72 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 133
9.3.1 UK 133
9.3.1.1 The UK is the largest market for veterinary antimicrobial susceptibility testing in Europe 133
FIGURE 42 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM 2015 TO 2019 (MG/KG) 134
TABLE 73 UK: PET POPULATION, 2016–2019 (MILLION) 134
FIGURE 43 NUMBER OF PRACTICING VETERINARIANS IN THE UK, 2013–2017 135
TABLE 74 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 135
TABLE 75 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 135
TABLE 76 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 77 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 78 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 136
9.3.2 GERMANY 137
9.3.2.1 Strict government regulations for AST to drive market growth in Germany 137
FIGURE 44 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011–2018) 137
TABLE 79 GERMANY: PET POPULATION, 2012–2019 (MILLION) 138
TABLE 80 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 138
TABLE 81 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 138
TABLE 82 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 83 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 84 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 139
9.3.3 FRANCE 140
9.3.3.1 Mandatory AST before prescribing antibiotics in animals to drive market growth 140
TABLE 85 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 140
TABLE 86 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 141
TABLE 87 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 141
TABLE 88 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 89 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 90 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 142
9.3.4 ITALY 142
9.3.4.1 Increasing food-producing animal population and growing awareness of AMR will generate high demand for AST in Italy 142
TABLE 91 ITALY: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 143
TABLE 92 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 143
TABLE 93 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 144
TABLE 94 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 95 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 96 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 145
9.3.5 SPAIN 145
9.3.5.1 Increasing demand for good quality animal-based food products is a major factor driving market growth 145
TABLE 97 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 146
TABLE 98 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 146
TABLE 99 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 146
TABLE 100 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 101 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 102 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 147
9.3.6 REST OF EUROPE (ROE) 148
TABLE 103 COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2018 (MILLION) 148
TABLE 104 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 149
TABLE 105 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 149
TABLE 106 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 107 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 108 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 150
9.4 ASIA PACIFIC (APAC) 150
TABLE 109 APAC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2018 (MILLION) 151
FIGURE 45 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 152
TABLE 110 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 111 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 153
TABLE 112 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 153
TABLE 113 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 114 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 115 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 154
9.4.1 CHINA 155
9.4.1.1 China dominated the APAC veterinary antimicrobial susceptibility testing market in 2020 155
TABLE 116 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION) 156
TABLE 117 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 156
TABLE 118 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 156
TABLE 119 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 120 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 121 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 157
9.4.2 JAPAN 158
9.4.2.1 Increasing risk of AMR due to high use of antimicrobial feed additives drives the market growth in Japan 158
FIGURE 46 VOLUME OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT) 159
FIGURE 47 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT) 159
TABLE 122 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 160
TABLE 123 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 160
TABLE 124 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 125 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 126 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 161
9.4.3 INDIA 161
9.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period 161
TABLE 127 INDIA: FOOD-PRODUCING ANIMAL POPULATION, 2010–2019 (MILLION) 162
TABLE 128 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 163
TABLE 129 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 163
TABLE 130 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 131 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 132 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY END USER, 2019–2026 (USD MILLION) 164
9.4.4 ROAPAC 164
TABLE 133 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 165
TABLE 134 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 165
TABLE 135 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 136 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 137 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 166
9.5 LATIN AMERICA 167
9.5.1 INCREASING BEEF AND POULTRY MEAT EXPORTS SUPPORTS THE MARKET GROWTH 167
TABLE 138 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 167
TABLE 139 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 168
TABLE 140 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 141 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 142 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 169
9.6 MIDDLE EAST & AFRICA 169
9.6.1 AVAILABILITY OF FUNDING TO PROMOTE ANIMAL HEALTHCARE IN THIS REGION SUPPORTS OVERALL MARKET GROWTH 169
TABLE 143 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
BY COUNTRY (2016 VS. 2018) 170
TABLE 144 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016 170
TABLE 145 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 170
TABLE 146 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 171
TABLE 147 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 148 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 149 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION) 172
10 COMPETITIVE LANDSCAPE 173
10.1 KEY PLAYER STRATEGIES 173
FIGURE 48 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2021 (JANUARY) 173
10.2 MARKET EVALUATION FRAMEWORK 173
FIGURE 49 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS 174
10.3 REVENUE ANALYSIS 174
FIGURE 50 REVENUE ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020 175
10.4 MARKET SHARE ANALYSIS 175
FIGURE 51 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 175
TABLE 150 COMPETITION ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020 176
10.5 COMPANY EVALUATION QUADRANT/DIVE MATRIX 177
10.5.1 STARS 177
10.5.2 EMERGING LEADERS 177
10.5.3 PERVASIVE PLAYERS 177
10.5.4 PARTICIPANTS 178
FIGURE 52 COMPANY EVALUATION QUADRANT/DIVE MATRIX: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 178
FIGURE 53 COMPANY PRODUCT FOOTPRINT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 179
10.6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHICAL ASSESSMENT 180
FIGURE 54 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020) 180
10.7 COMPETITIVE SITUATION AND TRENDS 180
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS 180
TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS (2017 – JANUARY 2021) 180
10.7.2 DEALS 181
TABLE 152 DEALS (2017–JANUARY 2021) 181
11 COMPANY PROFILES 182
11.1 SUPPLY-SIDE PLAYERS 182
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1.1 THERMO FISHER SCIENTIFIC INC. 182
TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 182
FIGURE 55 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019) 183
11.1.2 BECTON, DICKINSON AND COMPANY 186
TABLE 154 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 186
FIGURE 56 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020) 187
11.1.3 BRUKER CORPORATION 189
TABLE 155 BRUKER CORPORATION: BUSINESS OVERVIEW 189
FIGURE 57 COMPANY SNAPSHOT: BRUKER CORPORATION (2019) 190
11.1.4 BIOMÉRIEUX SA. 192
TABLE 156 BIOMÉRIEUX: BUSINESS OVERVIEW 192
FIGURE 58 COMPANY SNAPSHOT: BIOMÉRIEUX S.A. (2019) 193
11.1.5 DANAHER CORPORATION 195
TABLE 157 DANAHER CORPORATION: BUSINESS OVERVIEW 195
FIGURE 59 COMPANY SNAPSHOT: DANAHER CORPORATION (2019) 196
11.1.6 BIO-RAD LABORATORIES, INC. 198
TABLE 158 BIO-RAD LABORATORIES: BUSINESS OVERVIEW 198
FIGURE 60 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020) 199
11.1.7 NEOGEN CORPORATION 201
TABLE 159 NEOGEN CORPORATION: BUSINESS OVERVIEW 201
FIGURE 61 COMPANY SNAPSHOT: NEOGEN CORPORATION (2020) 202
11.1.8 HIMEDIA LABORATORIES 203
TABLE 160 HIMEDIA LABORATORIES: BUSINESS OVERVIEW 203
11.1.9 MAST GROUP LTD. 204
TABLE 161 MAST GROUP LTD.: BUSINESS OVERVIEW 204
11.1.10 BIOGUARD CORPORATION 206
TABLE 162 BIOGUARD CORPORATION: BUSINESS OVERVIEW 206
11.1.11 SSI DIAGNOSTICA A/S 207
TABLE 163 SSI DIAGNOSTICA A/S: BUSINESS OVERVIEW 207
11.1.12 CONDALAB 208
TABLE 164 CONDALAB: BUSINESS OVERVIEW 208
11.1.13 FASTINOV SA 209
TABLE 165 FASTINOV SA: BUSINESS OVERVIEW 209
11.1.14 SYNBIOSIS 210
TABLE 166 SYNBIOSIS: BUSINESS OVERVIEW 210
11.1.15 HARDY DIAGNOSTICS 211
TABLE 167 HARDY DIAGNOSTICS: BUSINESS OVERVIEW 211
11.1.16 LIOFILCHEM SRL. 213
TABLE 168 LIOFILCHEM SRL: BUSINESS OVERVIEW 213
11.2 DEMAND-SIDE PLAYERS 214
11.2.1 IDEXX REFERENCE LABORATORIES 214
TABLE 169 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW 214
FIGURE 62 COMPANY SNAPSHOT: IDEXX LABORATORIES, INC. (2020) 215
11.2.2 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY) 216
11.2.3 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY) 217
11.2.4 CORNELL UNIVERSITY (ANIMAL HEALTH DIAGNOSTIC CENTER) 218
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 219
12.1 DISCUSSION GUIDE 219
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 223
12.3 AVAILABLE CUSTOMIZATIONS 225
12.4 RELATED REPORTS 225
12.5 AUTHOR DETAILS 227

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127